MLchartDataset catalogue

MORAb-009

Term · Oncology and biomedicine · MLC-T-ONC-005501

A substance being studied in the treatment of mesothelioma. MORAb-009 binds to a protein called mesothelin, which is found on some cancer cells. MORAb-009 may help the immune system kill cancer cells. It is a type of monoclonal antibody. Also called amatuximab and anti-mesothelin monoclonal antibody MORAb-009.

Table 1. Record
IdentifierMLC-T-ONC-005501
FieldOncology and biomedicine
Expansionsamatuximab; anti-mesothelin monoclonal antibody MORAb-009
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-005501",
  "term": "MORAb-009",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of mesothelioma. MORAb-009 binds to a protein called mesothelin, which is found on some cancer cells. MORAb-009 may help the immune system kill cancer cells. It is a type of monoclonal antibody. Also called amatuximab and anti-mesothelin monoclonal antibody MORAb-009.",
  "expansions": [
    "amatuximab",
    "anti-mesothelin monoclonal antibody MORAb-009"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/morab-009/"
}

Record 11,273 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.